lorlatinib 25 MG Oral Tablet [Lorbrena]

RxCUI: 2103175
RxNorm name: lorlatinib 25 MG Oral Tablet [Lorbrena]
Display name: lorlatinib 25 MG Oral Tablet [Lorbrena]
Full name: lorlatinib 25 MG Oral Tablet [Lorbrena]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lorbrena	LORLATINIB	Pfizer Laboratories Div Pfizer Inc	2b34d62d-e02a-4af3-bc0d-1571dd4ee76d	2026-06-26	Warnings, Adverse reactions	Exact identifier rxcui: 2103175
Lorbrena	LORLATINIB	U.S. Pharmaceuticals	004f93d7-a1cd-4b67-9207-31cdcb5c5976	2026-02-13	Warnings, Adverse reactions	Exact identifier rxcui: 2103175

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2b34d62d-e02a-4af3-bc0d-1571dd4ee76d	LORBRENA 25 MG Oral Tablet [PSN] · lorlatinib 25 MG Oral Tablet [Lorbrena] [SBD] · Lorbrena 25 MG Oral Tablet [SY]	3	12	These highlights do not include all the information needed to use LORBRENA safely and effectively. See full prescribing information for LORBRENA. LORBRENA ® (lorlatinib) tablets, for oral use Initial U.S. Approval: 2018	20260209
004f93d7-a1cd-4b67-9207-31cdcb5c5976	LORBRENA 25 MG Oral Tablet [PSN] · lorlatinib 25 MG Oral Tablet [Lorbrena] [SBD] · Lorbrena 25 MG Oral Tablet [SY]	3	3	These highlights do not include all the information needed to use LORBRENA safely and effectively. See full prescribing information for LORBRENA. LORBRENA ® (lorlatinib) tablets, for oral use Initial U.S. Approval: 2018	20260213